Quantum-Si (NASDAQ:QSI) CFO Jeffry Keyes Sells 37,382 Shares of Stock

Quantum-Si Incorporated (NASDAQ:QSIGet Free Report) CFO Jeffry Keyes sold 37,382 shares of Quantum-Si stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $1.01, for a total value of $37,755.82. Following the completion of the transaction, the chief financial officer owned 1,769,963 shares of the company’s stock, valued at $1,787,662.63. The trade was a 2.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Quantum-Si Trading Up 8.5%

Shares of QSI stock opened at $1.06 on Thursday. The firm has a fifty day moving average price of $0.90 and a 200 day moving average price of $1.28. The company has a market cap of $229.35 million, a P/E ratio of -2.04 and a beta of 3.08. Quantum-Si Incorporated has a 12 month low of $0.69 and a 12 month high of $3.10.

Quantum-Si (NASDAQ:QSIGet Free Report) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.06. The firm had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. On average, equities analysts forecast that Quantum-Si Incorporated will post -0.5 EPS for the current year.

Institutional Trading of Quantum-Si

Hedge funds and other institutional investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Quantum-Si during the third quarter worth about $84,000. Jones Financial Companies Lllp increased its position in shares of Quantum-Si by 99.4% during the third quarter. Jones Financial Companies Lllp now owns 93,500 shares of the company’s stock worth $139,000 after purchasing an additional 46,600 shares in the last quarter. SBI Securities Co. Ltd. increased its position in shares of Quantum-Si by 28.6% during the third quarter. SBI Securities Co. Ltd. now owns 33,616 shares of the company’s stock worth $47,000 after purchasing an additional 7,475 shares in the last quarter. Capital Investment Advisory Services LLC increased its position in shares of Quantum-Si by 100.0% during the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after purchasing an additional 10,000 shares in the last quarter. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd increased its position in shares of Quantum-Si by 61.9% during the third quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 189,174 shares of the company’s stock worth $267,000 after purchasing an additional 72,346 shares in the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on QSI shares. Canaccord Genuity Group lowered their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research note on Friday, March 27th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $3.25.

Check Out Our Latest Stock Analysis on Quantum-Si

About Quantum-Si

(Get Free Report)

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.

See Also

Insider Buying and Selling by Quarter for Quantum-Si (NASDAQ:QSI)

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.